We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




ML Tool Alerts Doctors to Patients’ Deteriorating Condition 2-8 Hours in Advance

By HospiMedica International staff writers
Posted on 02 Sep 2022

With the massive amount of data in electronic medical records (EMRs) comes the potential for better patient care. More...

For example, the information from the data can be used to help medical staff make decisions that can prevent a patient’s deterioration from adverse events and acute illness. Up until recently, and still in some hospitals, patient data was not available electronically, restricting the capacity to develop digital tools to benefit from it. Now, a study to develop a machine learning tool which provides an early warning to medical professionals of a patient’s deteriorating condition has shown that the early warning deterioration alerts can be set to monitor patients two to eight hours before they are triggered by current clinical criteria.

The machine learning tool developed by scientists from the Commonwealth Scientific and Industrial Research Organization (CSIRO, Canberra, Australia), Australia's national science agency, will allow medical professionals to now use the data contained in EMRs to predict when a patient’s vital signs such as blood pressure or temperature are likely to reach a danger zone, triggering patient decline. The CSIRO scientists are now in discussion with partners for a clinical trial to explore how the alerts work and how they can be best implemented into clinical workflows.

“Until now there hasn’t been a way to harness all the data in the EMR to predict patient health. This new tool has the potential to transform the day-to-day functioning of health systems,” said CSIRO scientist Dr. Sankalp Khanna. “When applied to a test cohort of 18,648 patient records, the tool achieved 100% for prediction windows two to eight hours in advance for patients that were identified at 95%, 85% and 70% risk of deterioration.”

“Our scientists hold expertise in transforming data into useable information to help guide clinical choices. The new tool also sets out the reasons for the warning, which can guide the choice of intervention,” added Dr. Khanna “The alerts warn medical staff when a patient is at risk of deterioration leading to possible death, cardiac arrest, or unplanned admission to ICU. The tool can notify of the need for clinical intervention. Clinical decision support tools such as these are a pre-emptive solution that can provide medical staff with an opportunity to intervene earlier to prevent adverse patient outcomes.”

Related Links:
CSIRO 


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Examination & Procedure Light
Vega 80
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.